prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review
These concerns underscore the need to follow-up and screen survivors of cancer for toxicities such as those mentioned and also to develop and provide effective interventions that carry the potential to prevent or ameliorate such adverse outcomes.